Frenova on Thursday announced its hire of Robin Wallace as the new executive director of clinical medical operations.
According to Kurt Mussina, Frenova vice president and general manager, Wallace brings 20-plus years of experience with “global drug, biologic and device trials of all phases, including IND to NDA/BLA submission, Phase 1 to Phase IIIb, pilot, pivotal and government-funded programs.”
“Robin will oversee all aspects of Frenova’s clinical operations, including trial management, vendor selection, staff development and mentorship,” Mussina said in a release. “She will also represent Frenova clinical operations with regulatory organizations and at industry conferences and meetings.”
Wallace has served in a variety senior-level management positions, including as Novartis’ Vaccines and Diagnostics senior clinical consultant.